2.1. Objectives

SK Sacha Daniëlle Kuil
SH Soemeja Hidad
CS Caroline Schneeberger
PS Pragya Singh
PR Paul Rhodes
MJ Menno Douwe de Jong
CV Caroline Elisabeth Visser
request Request a Protocol
ask Ask a question
Favorite

The primary objective of this study was to assess the performance of the SpecifAST® system compared to the VITEK®2 system. Performance was measured by the categorical agreement, defined as agreement for the same categorical interpretation (susceptible (S), susceptible increased exposure (I), or resistant (R)) based on MIC values, in accordance with the 2021 European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints [25]. The analysis time in hours and number of Colony Forming Units per milliliter (CFU/mL) were measured as secondary objectives.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A